ARMP
Armata Pharmaceuticals Inc
3.90$
+5.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +32.6% | +8.2% | -0.6% | -0.6% | +21.4% | -0.8% | -2.9% | +1.1% | +13.0% | +9.3% | +254.0% | – | |
| – | – | +176.7% | +150.0% | -49.8% | -47.2% | +120.6% | -26.4% | +8.2% | +1.6% | +70.1% | +215.4% | – | |
| – | +505.4% | -403.8% | – | – | – | -200.7% | – | – | -101.8% | – | -423.7% | – | |
| – | -31.7% | -89.6% | +446.4% | -75.1% | -77.4% | +28.6% | +50.5% | +62.4% | -78.5% | +21.2% | -73.0% | – | |
| – | -31.9% | -89.5% | +446.4% | -75.1% | – | -228.6% | +50.5% | +62.4% | -78.5% | +21.2% | -73.0% | – | |
| – | – | – | – | – | – | – | – | – | -56.3% | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | -100.0% | – | – | – | |
| – | -100.2% | – | -99.7% | -169.3% | -100.0% | – | -100.0% | – | -95.6% | -2.6% | +4,249.6% | – | |
| – | -190.8% | – | -147.1% | – | – | – | -419.0% | – | -158.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.